SIRT1 and cancer: This finding is consistent with previous studies on several cytosolic targets that can be deacetylated and activated by SIRT1, including key EMT markers such as E-cadherin and cancer growth signaling ones such as IGF-1 and PI3K/Akt [5,6,7].